EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma

Ahmad Nofal, Rania Alakad, Reham Wahid, Heba Allah Mohamed Hoseiny

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-03139-1 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Ahmad Nofal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, Venereology &Andrology Department, Zagazig University Hospitals, Zagazig University, Zagazig, Egypt. Hauptthemen laut MEDLINE: Methotrexate, Fluorouracil, Keratoacanthoma, Injections, Intralesional. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zagazig University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Keratoacanthoma (KA) is a benign neoplasm that affects mainly photodamaged skin. It is locally destructive and may rarely spread. Surgery is not always suitable and usually disfiguring. Thus, non-operative modalities represent good alternatives.

Objective

To assess and compare the efficacy of intralesional methotrexate (MTX) and 5-flurouracil (5-FU) in the treatment of KA. Patients and methods Randomized controlled trial included 20 patients with biopsy proven KA divided into 2 equal groups; group (A) received intralesional MTX, 25 mg/ml and group (B) received intralesional 5-FU, 50 mg/ml every 2 weeks till complete clearance or for a maximum 5 sessions.

Results

In the MTX group, complete clearance was observed in 7 patients (70%) compared to 8 patients (80%) in the 5- FU group with no statistically significant difference. However, the median number of injections needed to achieve complete response in the MTX group was 3 sessions versus only 2 sessions in the 5-FU group. Limitations the small sample size due to the relatively low incidence of KAs in our population.

Conclusion

Intralesional therapy is a good alternative to surgery in selected cases of KA. Both drugs showed comparable efficacy, but 5-FU may give faster results, hence increasing patient satisfaction and compliance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateFluorouracilKeratoacanthomaInjections, IntralesionalHumansFemaleMaleMiddle AgedAgedTreatment OutcomeAdultAntimetabolites, AntineoplasticAged, 80 and over

Stichwörter der Autor:innen

5-flurouracilIntralesionalKeratoacanthomaMethotrexate

Substanzen

MethotrexateFluorouracilAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Dermatology, Venereology &Andrology Department, Zagazig University Hospitals, Zagazig University, Zagazig, Egypt.
  • Physiology Department, Zagazig University Hospitals, Zagazig University, Zagazig, Egypt.
  • Dermatology, Venereology &Andrology Department, Zagazig University Hospitals, Zagazig University, Zagazig, Egypt. hmhusiny@medicine.zu.edu.eg.

Förderung

  • Zagazig University

Zitieren

APA

Nofal, A., Alakad, R., Wahid, R., & Hoseiny, H. A. M. (2024). Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03139-1

Vancouver

Nofal A, Alakad R, Wahid R, Hoseiny HAM. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03139-1

BibTeX
@article{Nofal2024,
  author = {Nofal, Ahmad and Alakad, Rania and Wahid, Reham and Hoseiny, Heba Allah Mohamed},
  title = {Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-03139-1}
}
Kostenlos starten →